Metagenomi, Accounts Payable from 2010 to 2024

MGX Stock   2.01  0.12  6.35%   
Metagenomi, Common Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 1.9 M in 2024. Accounts Payable is the amount Metagenomi, Common Stock owes to suppliers or vendors for products or services received but not yet paid for. It represents Metagenomi, Common's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
2.1 M
Current Value
1.9 M
Quarterly Volatility
273.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Metagenomi, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Metagenomi, Common's main balance sheet or income statement drivers, such as Tax Provision of 9.7 M, Net Interest Income of 18.7 M or Interest Income of 18.7 M, as well as many indicators such as Price To Sales Ratio of 8.21, Dividend Yield of 0.0 or Days Sales Outstanding of 18.99. Metagenomi, financial statements analysis is a perfect complement when working with Metagenomi, Common Valuation or Volatility modules.
  
Check out the analysis of Metagenomi, Common Correlation against competitors.

Latest Metagenomi, Common's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Metagenomi, Common Stock over the last few years. An accounting item on the balance sheet that represents Metagenomi, Common obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Metagenomi, Common Stock are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Metagenomi, Common's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Metagenomi, Common's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Metagenomi, Accounts Payable Regression Statistics

Arithmetic Mean1,509,746
Geometric Mean1,489,290
Coefficient Of Variation18.09
Mean Deviation228,427
Median1,354,000
Standard Deviation273,153
Sample Variance74.6B
Range705.6K
R-Value0.75
Mean Square Error35.3B
R-Squared0.56
Significance0
Slope45,724
Total Sum of Squares1T

Metagenomi, Accounts Payable History

20241.9 M
20232.1 M
20221.8 M
2021M

About Metagenomi, Common Financial Statements

Metagenomi, Common investors use historical fundamental indicators, such as Metagenomi, Common's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Metagenomi, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable2.1 M1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Metagenomi, Stock Analysis

When running Metagenomi, Common's price analysis, check to measure Metagenomi, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi, Common is operating at the current time. Most of Metagenomi, Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi, Common's price. Additionally, you may evaluate how the addition of Metagenomi, Common to your portfolios can decrease your overall portfolio volatility.